New Bacterial Vaccines

New Bacterial Vaccines

In recent years, with the advent of recombinant DNA technology and major breakthroughs in molecular biology and immunology, a new dimension has been given to the design of vaccine strains. Powerful genetic and immunological technigues allow the production of new vaccines. In this article Haemophilus...

Full description

Bibliographic Details
Main Authors:	Işık YALÇIN, Ayşe PALANDUZ
Format:	Article
Language:	English
Published:	Bilimsel Tip Yayinevi 1996-09-01
Series:	Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:	Haemophilus influenzae vaccine Acellular Pertusis Vaccine Pneumococcal Polysaccharide Vaccine Meningococcal Polysaccharide Vaccine Typhoid Vaccine
Online Access:	http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=1996-1-3-192-197.pdf

Similar Items

Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
by: M. V. Abramtseva, et al.
Published: (2021-07-01)

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China
by: Mengdi Ji, et al.
Published: (2022-11-01)

Vaccine Uptake to Prevent Meningitis and Encephalitis in Shanghai, China
by: Hairenguli Maimaiti, et al.
Published: (2022-11-01)

Individual protection and population effect – two sides of one medal
by: G. L. Ignatova, et al.
Published: (2018-10-01)

Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation
by: Ezgi Demirdogen Cetinoglu, et al.
Published: (2017-09-01)

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
by: Angel Vila-Córcoles, et al.
Published: (2023-04-01)

Vaccination Coverage among Immunocompromised Patients in a Large Health Maintenance Organization: Findings from a Novel Computerized Registry
by: Shirley Shapiro Ben David, et al.
Published: (2022-10-01)

Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups
by: Yan Liu, et al.
Published: (2021-01-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
by: Salil Bendre, et al.
Published: (2024-02-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
by: Salil Bendre, et al.
Published: (2024-02-01)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023-08-01)

A description of a pre-emptive typhoid Vi capsular polysaccharide vaccination campaign after the 2015 earthquake in Nepal and vaccine effectiveness evaluation
by: Bhim Gopal Dhoubhadel, et al.
Published: (2024-01-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group
by: Esther Redondo, et al.
Published: (2023-01-01)

Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia
by: Vesa Lindström, et al.
Published: (2019-12-01)

Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis
by: Kaile Chen, et al.
Published: (2018-06-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

The remarkable history of pneumococcal vaccination: an ongoing challenge
by: Daniel M. Musher, et al.
Published: (2022-09-01)

Predictors of yearly influenza vaccination in hospitalized and community based patients
by: Stephanie Attard Camilleri, et al.
Published: (2018-08-01)

Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection
by: M. V. Savkina, et al.
Published: (2021-12-01)

Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ
by: Starla Hayward, et al.
Published: (2016-04-01)

30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization
by: Tianjing Hu, et al.
Published: (2022-11-01)

Pneumococcal and Influenza Vaccination Coverage Rates of Adult Patients at Risk and Their Attitudes Towards Vaccination
by: Lale ÖZIŞIK, et al.
Published: (2016-03-01)

Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal
by: Shakya, M
Published: (2022)

A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
by: James Campling, et al.
Published: (2023-12-01)

Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial
by: Kei Nakashima, et al.
Published: (2018-08-01)

Awareness of Influenza and Pneumococcal Vaccination in the Geriatric Age Group
by: Süheyla AYDOĞMUŞ, et al.
Published: (2010-12-01)

The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects
by: Ioanna Papadatou, et al.
Published: (2019-01-01)

Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study
by: Chieh Lan, et al.
Published: (2023-05-01)

PREVENTION OF MENINGOCOCCAL INFECTION
by: I. V. FRIDMAN, et al.
Published: (2017-05-01)

Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
by: Tamas Fulop, et al.
Published: (2022-04-01)

Meningococcal vaccines in China
by: Yinghua Xu, et al.
Published: (2021-07-01)

Do vaccinations influence the development of Alzheimer disease?
by: Avram S. Bukhbinder, et al.
Published: (2023-08-01)

Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)
by: Ulrike K. Buchwald, et al.
Published: (2021-01-01)

Promising directions for vaccine development to prevent shigellosis
by: M. V. Abramtseva, et al.
Published: (2022-10-01)

Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?
by: Alice Laurence, et al.
Published: (2016-06-01)

Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis
by: Andrea Conti, et al.
Published: (2023-01-01)

Invasive Bacterial Diseases in Northern Canada
by: Naushaba Degani, et al.
Published: (2008-01-01)